An Insulin-Like Growth Factor-I Promoter Polymorphism Is Associated With Increased Mortality in Subjects With Myocardial Infarction in an Elderly Caucasian Population

American Journal of Cardiology

Volumn 97, Issue 9, 2006, Pages 1274-1276

  Yazdanpanah, Mojgan ^a   Rietveld, Ingrid ^a   Janssen, Joop A M J L ^a   Njajou, Omer T ^a   Hofman, Albert ^a   Stijnen, Theo ^a   Pols, Huibert A P ^a   Lamberts, Steven W J ^a   Witteman, Jacqueline C M ^a   van Duijn, Cornelia M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENETIC VARIABILITY; HEART INFARCTION; HETEROZYGOTE; HUMAN; MALE; MORTALITY; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR;

AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; FOLLOW-UP STUDIES; HETEROZYGOTE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MYOCARDIAL INFARCTION; NETHERLANDS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROPORTIONAL HAZARDS MODELS;

EID: 33646031201     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.11.069     Document Type: Article

References (7)

1. Ren J., Samson W.K., and Sowers J.R. Insulin-like growth factor I as a cardiac hormone. physiological and pathophysiological implications in heart disease. J Mol Cell Cardiol 31 (1999) 2049-2061
2. Conti E., Andreotti F., Sciahbasi A., Riccardi P., Marra G., Menini E., Ghirlanda G., and Maseri A. Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction. J Am Coll Cardiol 38 (2001) 26-32
3. Hong Y., Pedersen N.L., Brismar K., Hall K., and de Faire U. Quantitative genetic analyses of insulin-like growth factor I (IGF-I), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins. J Clin Endocrinol Metab 81 (1996) 1791-1797
4. Vaessen N., Heutink P., Janssen J.A., Witteman J.C., Testers L., Hofman A., Lamberts S.W., Oostra B.A., Pols H.A., and van Duijn C.M. A polymorphism in the gene for IGF-I. functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 50 (2001) 637-642
5. Rietveld I., Janssen J.A., van Rossum E.F., Houwing-Duistermaat J.J., Rivadeneria F., Hofman A., Pols H.A., van Duijn C.M., and Lamberts S.W. A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height. Clin Endocrinol 61 (2004) 195-203
6. Bleumink G.S., Rietveld I., Janssen J.A.M.J.L., van Rossum E.F.C., Deckers J.W., Hofman A., Witteman J.C.M., van Duijn C.M., and Stricker B.H.C. Insulin-like growth factor-I gene polymorphism and risk of heart failure (the Rotterdam Study). Am J Cardiol 94 (2004) 384-386
7. Li B., Setoguchi M., Wang X., Andreoli A.M., Leri A., Malhotra A., Kajstura J., and Anversa P. Insulin-like growth factor-1 attenuates the detrimental impact of nonocclusive coronary artery constriction on the heart. Circ Res 84 (1999) 1007-1019